Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Healthtrust
Accenture
Cipla
QuintilesIMS
Deloitte
AstraZeneca
Express Scripts
McKesson
Chubb

Generated: August 22, 2017

DrugPatentWatch Database Preview

PHENTERMINE RESIN COMPLEX Drug Profile

« Back to Dashboard

What is the patent landscape for Phentermine Resin Complex, and when can generic versions of Phentermine Resin Complex launch?

Phentermine Resin Complex is a drug marketed by Lannett Holdings Inc and is included in one NDA.

The generic ingredient in PHENTERMINE RESIN COMPLEX is phentermine resin complex. There are seventeen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the phentermine resin complex profile page.

Summary for Tradename: PHENTERMINE RESIN COMPLEX

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list20
Clinical Trials: see list1,547
Patent Applications: see list4,636
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PHENTERMINE RESIN COMPLEX at DailyMed

Pharmacology for Tradename: PHENTERMINE RESIN COMPLEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lannett Holdings Inc
PHENTERMINE RESIN COMPLEX
phentermine resin complex
CAPSULE, EXTENDED RELEASE;ORAL040872-001Jul 28, 2011DISCNNoNo► Subscribe► Subscribe► Subscribe
Lannett Holdings Inc
PHENTERMINE RESIN COMPLEX
phentermine resin complex
CAPSULE, EXTENDED RELEASE;ORAL040872-002Jul 28, 2011DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Covington
Daiichi Sankyo
Baxter
UBS
Healthtrust
Cipla
Fuji
Deloitte
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot